Today, Quantitative Investment Management LLC Buys 19,300 Shares of Parexel International Corp. (PRXL)

Today, Quantitative Investment Management LLC Buys 19,300  Shares of Parexel International Corp. (PRXL)

Quantitative Investment Management LLC acquired a new stake in Parexel International Corp. (NASDAQ:PRXL) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 19,300 shares of the company’s stock, valued at approximately $1,340,000.

A number of other hedge funds have also recently modified their holdings of the company. Quantbot Technologies LP boosted its stake in shares of Parexel International Corp. by 644.3% in the second quarter. Quantbot Technologies LP now owns 1,630 shares of the company’s stock valued at $102,000 after buying an additional 1,411 shares in the last quarter. MSI Financial Services Inc boosted its stake in shares of Parexel International Corp. by 17.4% in the third quarter. MSI Financial Services Inc now owns 1,690 shares of the company’s stock valued at $117,000 after buying an additional 250 shares in the last quarter. Robecosam AG boosted its stake in shares of Parexel International Corp. by 40.1% in the second quarter. Robecosam AG now owns 2,200 shares of the company’s stock valued at $132,000 after buying an additional 630 shares in the last quarter. Paradigm Asset Management Co. LLC boosted its stake in shares of Parexel International Corp. by 683.3% in the second quarter. Paradigm Asset Management Co. LLC now owns 2,350 shares of the company’s stock valued at $148,000 after buying an additional 2,050 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Parexel International Corp. by 3,367.1% in the second quarter. Tower Research Capital LLC TRC now owns 2,843 shares of the company’s stock valued at $179,000 after buying an additional 2,761 shares in the last quarter. 96.13% of the stock is currently owned by hedge funds and other institutional investors.

Parexel International Corp. (NASDAQ:PRXL) remained flat at $58.16 during midday trading on Thursday. The company’s stock had a trading volume of 1,083,520 shares. The firm has a market cap of $3.10 billion, a price-to-earnings ratio of 18.64 and a beta of 0.91. The firm has a 50-day moving average price of $62.05 and a 200 day moving average price of $64.14. Parexel International Corp. has a 12 month low of $51.16 and a 12 month high of $71.13.

Parexel International Corp. (NASDAQ:PRXL) last announced its quarterly earnings results on Wednesday, October 26th. The company reported $0.76 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by $0.10. The company had revenue of $500.90 million for the quarter, compared to the consensus estimate of $525.15 million. Parexel International Corp. had a net margin of 7.09% and a return on equity of 30.71%. The company’s revenue for the quarter was down 2.2% compared to the same quarter last year. During the same period last year, the firm posted $0.70 earnings per share. Equities research analysts forecast that Parexel International Corp. will post $3.75 EPS for the current fiscal year.

Several analysts have weighed in on the stock. Wells Fargo & Co. cut shares of Parexel International Corp. from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Evercore ISI reiterated a “buy” rating and set a $78.50 target price (up from $71.00) on shares of Parexel International Corp. in a research report on Friday, August 5th. Jefferies Group reduced their target price on shares of Parexel International Corp. from $67.00 to $64.00 and set a “hold” rating on the stock in a research report on Wednesday. Citigroup Inc. upped their target price on shares of Parexel International Corp. from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, August 5th. Finally, Credit Suisse Group AG reiterated a “buy” rating on shares of Parexel International Corp. in a research report on Wednesday, November 16th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $66.70.

Parexel International Corp. Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world.

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Parexel International Corp. (NASDAQ:PRXL).

Receive News & Ratings for Parexel International Corp. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Parexel International Corp. and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment